Research Projects EU Structural funds 2014-2020
Projects

EU STRUCTURAL FUNDS 2014 - 2020

 

 

European Regional Development Fund (ERDF)

Operational Programme Growth and Employment

1.1.1 Specific Aid Objective To increase the research and innovative capacity of scientific institutions of Latvia and the ability to attract external financing, investing in human resources and infrastructure

First selection round projects

1.1.1.1/16/A/044
Assessment of magnitude and importance of vectorborne Babesiosis in Latvia: epidemiological and diagnostic approach

1.1.1.1/16/A/054
Diagnostic and immunoprotective potential of influenza virus hemagglutinin stalk peptide: generation of novel vaccine prototypes

1.1.1.1/16/A/055
Development of orphan G-protein coupled receptor peptidic ligand identification system

1.1.1.1/16/A/066
Molecular markers of pituitary tumor development, progression and therapy response

1.1.1.1/16/A/091
Investigation of interplay between multiple determinants influencing response to metformin: search for reliable predictors for efficacy of type 2 diabetes therapy

1.1.1.1/16/A/101
The impact of burial environmental microbiome on biomolecular archeology and the ancient tuberculosis research

1.1.1.1/16/A/104
Obtaining and characterization of virus-like particles of novel RNA phages

1.1.1.1/16/A/107
Development of new antimicrobial agents targeting Gram-positive bacterial sortase A

1.1.1.1/16/A/211
Molecular design of new luminescent compounds for diagnostic purposes

1.1.1.1/16/A/272
Long term effects of H.pylori eradication on Gastro intestinal tract microbiome and development of screening system for detection of extended-spectrum beta-lactamase coding genes within feces samples

Second selection round projects

1.1.1.1/18/A/026

Studies on Ribes plants, Cecidophyopsis mites and Blackcurrant Reversion virus for sustainable resistance breeding and cultivation of Ribes

1.1.1.1/18/A/099

Understanding the biology of the minimal residual disease after targeted therapy of BRAF mutant melanoma

1.1.1.1/18/A/084

Clinical utility of extracellular vesicle-enclosed human and microbial transcriptomes

1.1.1.1/18/A/089

RNA molecular determinants in development of pituitary adenoma

1.1.1.1/18/A/092

Role of miRNAs in the host-gut microbiome communication during metformin treatment in the context of metabolic disorders

1.1.1.1/18/A/096

The determination of rare inherited diseases' causative mechanisms using whole genome sequencing approach

1.1.1.1/18/A/097

Functional and genetic research of rare unidentitied neuromuscular disorders

Third selection round project

1.1.1.1/19/A/036

Interaction and dynamics of intestinal IgA and gut microbiome profile during antidiabetic therapy

Fourth selection round projects

1.1.1.1/20/A/046

Whole genome sequencing of tuberculosis for routine clinical use in Latvia: evidence-based design and concept evaluation

1.1.1.1/20/A/047

DECIDE - Development of a dynamic informed consent system for biobank and citizen science data management, quality control and integration

1.1.1.1/20/A/048

Usage of conservative borrelia protein as vaccine target

1.1.1.1/20/A/124

Testing of patient-derived stem cell extracellular vesicles loaded with drugs in a personalized lung-cancer on-chip platform (LoC4Ev)

1.1.1.1/20/A/126

European Regional Development Fund (ERDF), Measure 1.1.1.1 “Support for applied research”


 

1.1.1.2. Activity Post-doctoral Research Aid

First selection round projects

1.1.1.2/VIAA/1/16/203
Engineering of extracellular vesicles to transfer tumor suppressor miRNA to cancer cells

1.1.1.2/VIAA/1/16/144
Structural and functional studies of Lyme disease agent Borrelia burgdorferi outer surface proteins to reveal the mechanisms of pathogenesis with the intention to create a new vaccine

1.1.1.2/VIAA/1/16/135
sRNAflow – a tool for analysis of small RNA-seq data

1.1.1.2/VIAA/1/16/128
Investigation of interaction of smoked dietary products with gut microbiome

Second selection round projects

1.1.1.2/VIAA/2/18/292
Role of natural killer cells in the therapeutic efficacy of oncolytic measles virus

1.1.1.2/VIAA/2/18/286 

Optimization of novel plant derived enzyme expression in microorganisms for biotechnological application

1.1.1.2/VIAA/2/18/285

Combination of system and molecular biology approaches for discovery and characterization of plant enzymes for industrial processes

1.1.1.2/VIAA/2/18/287

Identification of clinical subgroups of Type 2 diabetes mellitus and application of pharmacogenetics in development of personalized antidiabetic therapy

Third selection round projects

1.1.1.2/VIAA/3/19/463

The role of “mitotic slippage” in the origin of amoeboid metastatic cell in therapy resistant cancers

1.1.1.2/VIAA/3/19/464

Structural and kinetic studies of human carbonic anhydrases as multiple drug targets

1.1.1.2/VIAA/3/19/462

Structural and functional studies of Ryegrass mottle virus-encoded proteins

1.1.1.2/VIAA/3/19/460

Association of human intestinal and blood microbiome composition with general state of health and mortality within population of Latvia

 Fourth selection round projects

1.1.1.2/VIAA/4/20/704

Structural studies of a Borrelia burgdorferi bacteriophage

1.1.1.2/VIAA/4/20/705

Development of a bacterial microcompartment-based nanoreactor platform for metal-containing nanoparticle synthesis

1.1.1.2/VIAA/4/20/728

Evaluation the potential of virus-like particles carrying carbonic anhydrase IX as anti-cancer vaccine

1.1.1.4 Development of the R&D Infrastructure in Fields of Smart Specialisation and Strengthening of Institutional Capacity of Scientific Institutions

1.1.1.4/17/I/ 009
Infrastructure of the Latvian Biomedical Research and Study Center for the strengthening of research and technology transfer capacities in the fields of biomedicine and biotechnology

1.1.1.1/20/A/ 045
Development of a novel microfluidic device for label-free quantification of prostate cancer-derived extracellular vesicles and analysis of their RNA content (PROCEX)

 

1.1.1.5. Support for International Cooperation Projects in Research and Innovation

1.1.1.5/18/I/006
Support for the integration of the Latvian Biomedical Research and Study Centre into the European Research Area and Infrastructure objects
 

1.1.1.5/20/A/002
European resercher Night in Latvia 2020


 

 

1.2.1. Specific Aid Objective To increase private sector investment in R&D

1.2.1.2. Activity Support for Improvement of Technology Transfer System

KC-PI-2017/23
Precision medicine test for the therapeutic decisions and monitoring of treatment response in breast cancer

KC-PI-2017/83
Plant virus-derived vaccine technology platform

  KC-PI-2017/84
Development of anti-Lyme disease vaccine candidate

KC-PI-2020/23
Development of anti-myostatin vaccine for promotion of livestock animal muscle growth

KC-PI-2020/30
Dynamic human microbiome data platform and interpretation tool for personalized health recommendations

Quick links



Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".